Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-14

FDA Approved: DRONABINOL — Supplemental Application (Camber Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for dronabinol from Camber Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)